Leveraging NVIDIA's Latest GPU Architecture to Accelerate Innovations in Ultra-Low-Dose Imaging and Enhanced Lesion Visualization
Medical imaging faces several critical challenges. Imaging modalities like MRI, PET, and CT are used in over five hundred million patients annually for diagnosis and treatment, involving long scan times and/or potentially high radiation and...
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has successfully secured a $110 million Series E financing led by a private equity fund of Value Partners Group, one of Asia's largest independent asset management firms, with strong participation from industry- and technology-focused new investors,...
Caliber has launched four digital solutions that strengthen its portfolio and position the company at the forefront of the Pharma 4.0 revolution. These innovations integrate AI and next-generation technologies to reinforce Caliber's commitment to future-proofing the life sciences industry through holistic digital enablement and optimized compliance.
With over 23 years of...
Flagship Pioneering, the bioplatform innovation company, unveiled Lila Sciences, a company building the world's first scientific superintelligence platform and fully autonomous labs for life, chemical, and materials sciences. The company, which was founded in Flagship's labs in 2023, is pioneering an advanced form of AI that can not only...
Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), announced to unveil its innovative AI-assisted drug discovery engine, Hu-mAtrIxTM. This new platform, powered by advanced artificial intelligence, integrates seamlessly with the company's proprietary Harbour Mice® technology platform, aiming to accelerate antibody discovery across...
ARUP Laboratories announced the expansion of its groundbreaking AI-augmented screening tool for the detection of human gastrointestinal parasites to include wet-mount slides. With this expansion, ARUP Laboratories will become the first and only laboratory to apply AI-augmented screening to the entire ova and parasite testing process.
"By utilizing an AI-augmented...
Enveric Biosciences, a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, announced the company will build on its recent business development momentum by soliciting Requests-For-Proposal (“RFPs”) for license or sale of its PsyAI™ trademark portfolio as a...
Synergy Laboratories, a leading full-service diagnostic laboratory, has launched Hologic's state-of-the-art Genius™ Digital Diagnostics System with Genius Cervical AI algorithm marking a significant advancement in cervical cancer screening and diagnostics. As the first to introduce this cutting-edge system to the Gulf Coast, Synergy Laboratories is setting a new benchmark for precision medicine,...
Collaboration brings together leading lung and breast imaging expertise to advance AI-driven cancer detection and early intervention.
Optellum, the leader in AI-enabled lung cancer diagnosis, announced it has entered a strategic agreement with Volpara Health, a Lunit company and a global leader in software for the early detection of cancer,...
Groundbreaking intelligence addresses a $1B industry problem, helping healthcare organizations streamline billing workflows and receive accurate reimbursement
DeepScribe, the ambient AI of choice for specialty and chronic care, announced automated Evaluation and Management (E/M) medical coding as the newest offering within its Ambient Operating System for clinicians. Part of DeepScribe Assist insights, E/M...
